Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 9, 2002, Pages 3054-3056

  Prunier, Anne Laure ^a   Malbruny, Brigitte ^a   Tandé, Didier ^a   Picard, Bertrand ^a   Leclercq, Roland ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENOMIC DNA; LINCOMYCIN; MACROLIDE; MIKAMYCIN B; PRISTINAMYCIN; QUINUPRISTIN; RIBOSOME PROTEIN; RIBOSOME RNA; RNA 23S; SPIRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CYSTIC FIBROSIS; DNA SEQUENCE; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIAL PROTEINS; CYSTIC FIBROSIS; DNA, BACTERIAL; DRUG RESISTANCE; ERYTHROMYCIN; GENES, BACTERIAL; HUMANS; MEMBRANE TRANSPORT PROTEINS; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MUTATION; OLIGONUCLEOTIDE PROBES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0036721299     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.9.3054-3056.2002     Document Type: Article

References (20)

1. Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae
2. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae
3. Antagonisme in vitro entre l'érythromycine et la spiramycine
4. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae
5. Microbiology of lung infection in cystic fibrosis
6. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis
7. Biofilm disease: Its clinical manifestation and therapeutic possibilities of macrolides
8. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
9. Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics
10. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci
11. Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus
12. A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus
13. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection
14. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family
15. Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals
16. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage
17. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America
18. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
19. Macrolide resistance conferred by base substitutions in 23S rRNA
20. Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides